6
Shared Docs
6
Same-Page
6 / 6
Mentions
tes: <7.0 Prostate-Specific Ag, Serum Prostate Specific Ag, Serum Roche ECLIA methodology. 0.8 ng/mL 4.8 - 5.6 02 0.0 - 4.0 02 According to the American Urological Association, Serum PSA should decrease and remain at undetectable levels after radical prostatectomy. The AUA defines biochemical recurrence as an initial PSA
Institute of 30.0 - 100.0 02 Medicine and an Endocrine Society practice guideline as a level of serum 25-0H vitamin D less than 20 ng/mL (1,2). The Endocrine Society went on to further define vitamin D insufficiency as a level between 21 and 29 ng/mL (2). 1. ION (Institute of Medicine). 2010. Dietary reference
3092 UulowbenKkb/403-2377 4 DatitcoftalictO9/114M81/nLMM TESTS RESULT FLAG UNITS REFERENCE INTERVAL LAB Roche ECLIA methodology. According to the American Urological Association, Serum PSA should decrease and remain at undetectable levels after radical prostatectomy. The AUA defines biochemical recurrence as an initial PSA
een defined by the Institute of Medicine and an Endocrine Society practice guideline as a level of serum 25-OH vitamin D less than 20 ng/mL (1,2). The Endocrine Society went on to further define vitamin D insufficiency as a level between 21 and 29 ng/aL (2) • 1. IOM (Institute of Medicine). 2010. Dietary reference
ults with diabetes: <7.0 Prostate-Specific Ag, Serum Prostate Specific Ag, Serum 0.7 ng/mL 0.0 - 4.0 01 Roche ECLIA methodology. According to the American Urological Association, Serum PSA should decrease and remain at undetectable levels after radical prostatectomy. The AUA defines biochemical recurrence as an initial PSA
en defined by the institute of Medicine and an Endocrine Society practice guideline as a level of serum 25-018 vitamin D less than 20 ng/mL (1,2). The Endocrine Society went on to further define vitamin D insufficiency as a level between 21 and 29 ng/mL (2). 1. ZOE (Institute of Medicine). 2010. Dietary reference
ITS REFERENCE INTERVAL LAB Prostate-Specific Ag, Serum Prostate Specific Ag, Serum Roche ECLIA methodology. 0.6 ng/mL 0.0 - 4.0 According to the American Urological Association, Serum PSA should decrease and remain at undetectable levels after radical prostatectomy. The AUA defines biochemical recurrence as an initial PSA
een defined by the Institute of Medicine and an Endocrine Society practice guideline as a level of serum 25-OH vitamin D less than 20 ng/mL (1,2). The Endocrine Society went on to further define vitamin D insufficiency as a level between 21 and 29 ng/mL (2). 1. IOM (Institute of Medicine). 2010. Dietary reference
257-S80-2371D Date collected:09/14/2018 1255 Local TESTS RESULT FLAG UNITS REFERENCE INTERVAL LAB TSH Roche ECLIA methodology. According to the American Urological Association, Serum PSA should decrease and remain at undetectable levels after radical prostatectomy. The AUA defines biochemical recurrence as an initial PSA
een defined by the Institute of Medicine and an Endocrine Society practice guideline as a level of serum 25-0H vitamin D less than 20 ng/mL (1,2). The Endocrine Society went on to further define vitamin D insufficiency as a level between 21 and 29 ng/mL (2). 1. IOM (Institute of Medicine). 2010. Dietary reference
with diabetes: <7.0 01 Prostate-Specific Ag, Serum Prostate Specific Ag, Serum 0.7 ng/mL 0.0 - 4.0 01 Roche ECLIA methodology. According to the American Urological Association, Serum PSA should decrease and remain at undetectable levels after radical prostatectomy. The AUA defines biochemical recurrence as an initial PSA
een defined by the Institute of Medicine and an Endocrine Society practice guideline as a level of serum 25-OH vitamin D less than 20 ng/mL (1,2). The Endocrine Society went on to further define vitamin D insufficiency as a level between 21 and 29 ng/mL (2). 1. IOM (Institute of Medicine). 2010. Dietary reference
Entities connected to both the American Urological Association and The Endocrine Society

Jeffrey Epstein
PERSONBischoff-Ferrari HA
ORGANIZATIONNational Academies Press
ORGANIZATIONC-Reactive Protein
ORGANIZATIONCardiac
ORGANIZATIONBurlington
LOCATIONRaritan
LOCATION
NEW YORK NY
LOCATIONWilliam F Hancock
PERSONHinkley NC
LOCATIONProstate-Specific Ag
ORGANIZATIONIron Bind
ORGANIZATIONBEI - Inorganic Mercury
ORGANIZATIONLabCorp Burlington
ORGANIZATIONMetabolic Panel
ORGANIZATIONNon Reactive
ORGANIZATIONIGF-1
ORGANIZATIONNon-Parathyroid Hypocalcemia
ORGANIZATIONLipid Panel
ORGANIZATIONAlkaline Phosphatase
PERSON